HomeENZY • STO
Enzymatica AB (publ)
Follow
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(SEK) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 17.16M | 8.38% |
Operating expense | 25.23M | 5.39% |
Net income | -13.28M | 5.56% |
Net profit margin | -77.38 | 12.86% |
Earnings per share | — | — |
EBITDA | -12.26M | 5.74% |
Effective tax rate | 0.31% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(SEK) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 75.21M | 799.02% |
Total assets | 195.22M | 55.05% |
Total liabilities | 18.86M | -61.76% |
Total equity | 176.37M | — |
Shares outstanding | 242.74M | — |
Price to book | 5.56 | — |
Return on assets | -16.83% | — |
Return on capital | -18.49% | — |
Cash Flow
Net Change in Cash
Net change in cash
(SEK) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -13.28M | 5.56% |
Cash from operations | -20.55M | -690.12% |
Cash from investing | -231.00K | 37.23% |
Cash from financing | -949.00K | 40.58% |
Net change in cash | -21.69M | -365.67% |
Free cash flow | -17.31M | -229.15% |
Previous close
kr4.06
Day range
kr4.00 - kr4.06
Year range
kr1.34 - kr5.45
Market cap
970.94M SEK
Avg Volume
315.16K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
About
Founded
2007
Website
Employees
21